Phase 2
๐ Investigational Drug / Biologic
NCT04696575
Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer
๐ Roswell Park Cancer Institute โ Buffalo, New York
View Study & Screener โ